Brion J P, Smith C, Couck A M, Gallo J M, Anderton B H
Laboratory of Pathology and Electron Microscopy, Université Libre de Bruxelles, Belgium.
J Neurochem. 1993 Dec;61(6):2071-80. doi: 10.1111/j.1471-4159.1993.tb07444.x.
Rat and human fetal brain tau were probed with a panel of monoclonal antibodies (tau-1, AT8, 8D8, RT97, SMI31, SMI34) that distinguish between paired helical filament (PHF)-tau of Alzheimer's disease and normal adult brain tau. These antibodies discriminate between normal and PHF-tau because their epitopes are phosphorylated in PHF-tau. Although only one molecular isoform of tau was shown to be expressed in fetal brain, two fetal tau species could be distinguished on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and the slower migrating species was recognized by all of the PHF-tau-specific antibodies. Moreover, this immunoreactivity was shown to be phosphorylation dependent. Our observations suggest that the abnormal phosphorylation of tau in Alzheimer's disease may be the result of reactivation of pathways governing the phosphorylation of tau in the developing brain.
用一组单克隆抗体(tau-1、AT8、8D8、RT97、SMI31、SMI34)检测大鼠和人类胎儿脑tau蛋白,这些抗体可区分阿尔茨海默病的成对螺旋丝(PHF)-tau蛋白和正常成人大脑tau蛋白。这些抗体能够区分正常tau蛋白和PHF-tau蛋白,因为它们的表位在PHF-tau蛋白中发生了磷酸化。尽管在胎儿脑中仅显示一种tau分子异构体表达,但在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳上可区分出两种胎儿tau蛋白种类,迁移较慢的种类可被所有PHF-tau特异性抗体识别。此外,这种免疫反应性显示为磷酸化依赖性。我们的观察结果表明,阿尔茨海默病中tau蛋白的异常磷酸化可能是发育中大脑中控制tau蛋白磷酸化的途径重新激活的结果。